magazine_ News

1

Molecule identified that could counteract arrhythmogenic cardiomyopathy

.

06 October 2022

MB-3 is a synthetic, lab-created molecule used to limit the activity of the enzyme GCN5 which reduces the accumulation of fat in heart cells that characterize arrhythmogenic cardiomyopathy – a disease that has affected young sportsmen such as Livorno soccer player Piermario Morosini and Asiago field hockey player Darcy Robinson. The discovery by a team of biologists from Eurac Research comes after several years of research in collaboration with the Medical University of Innsbruck, the Monzino Cardiology Center and the University of Milan.

Related People

Alessandra Rossini

Marzia De Bortoli

Peter P. Pramstaller

Chiara Volani

Reginald Philippe

Tags

Institutes & Centers


Related Content

interview

AHIA!

Una ricercatrice e un disegnatore raccontano il dolore in un fumetto

news

Riprogrammazione efficace delle cellule tumorali

Uno studio dimostra l'efficacia di una molecola contro il leiomiosarcoma - l'aggressivo cancro dei tessuti molli - e identifica alcuni geni che permettono una prognosi migliore